- Home
- SLRX vs KRMD Comparison
SLRX vs KRMD Comparison
Compare SLRX & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- KRMD
- Stock Information
- Founded
- SLRX N/A
- KRMD 1980
- Country
- SLRX United States
- KRMD United States
- Employees
- SLRX N/A
- KRMD N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- SLRX Health Care
- KRMD Health Care
- Exchange
- SLRX Nasdaq
- KRMD Nasdaq
- Market Cap
- SLRX N/A
- KRMD 103.4M
- IPO Year
- SLRX N/A
- KRMD N/A
- Fundamental
- Price
- SLRX $0.73
- KRMD $2.47
- Analyst Decision
- SLRX
- KRMD Strong Buy
- Analyst Count
- SLRX 0
- KRMD 4
- Target Price
- SLRX N/A
- KRMD $4.88
- AVG Volume (30 Days)
- SLRX 257.2K
- KRMD 145.7K
- Earning Date
- SLRX 05-12-2025
- KRMD 05-07-2025
- Dividend Yield
- SLRX N/A
- KRMD N/A
- EPS Growth
- SLRX N/A
- KRMD N/A
- EPS
- SLRX N/A
- KRMD N/A
- Revenue
- SLRX N/A
- KRMD $33,646,463.00
- Revenue This Year
- SLRX N/A
- KRMD $16.50
- Revenue Next Year
- SLRX N/A
- KRMD $15.47
- P/E Ratio
- SLRX N/A
- KRMD N/A
- Revenue Growth
- SLRX N/A
- KRMD 17.98
- 52 Week Low
- SLRX $0.45
- KRMD $1.86
- 52 Week High
- SLRX $7.20
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- SLRX 44.60
- KRMD 46.18
- Support Level
- SLRX $0.61
- KRMD $2.36
- Resistance Level
- SLRX $0.75
- KRMD $2.52
- Average True Range (ATR)
- SLRX 0.09
- KRMD 0.22
- MACD
- SLRX 0.03
- KRMD 0.06
- Stochastic Oscillator
- SLRX 70.53
- KRMD 91.04
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).